Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,232
  • Shares Outstanding, K 25,750
  • Annual Sales, $ 930 K
  • Annual Income, $ -27,790 K
  • 60-Month Beta 1.32
  • Price/Sales 42.60
  • Price/Cash Flow N/A
  • Price/Book 0.38
Trade EVGN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.69
  • Most Recent Earnings -0.18 on 03/10/22
  • Next Earnings Date 05/26/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 254.44% ( -74.45%)
  • Historical Volatility 66.82%
  • IV Percentile 77%
  • IV Rank 33.47%
  • IV High 625.70% on 02/28/22
  • IV Low 67.63% on 11/05/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 1,499
  • Open Int (30-Day) 3,163

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +17.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8100 +11.57%
on 05/11/22
1.1100 -18.59%
on 05/06/22
-0.1563 (-14.75%)
since 04/26/22
3-Month
0.8100 +11.57%
on 05/11/22
1.6200 -44.22%
on 03/10/22
-0.2163 (-19.31%)
since 02/25/22
52-Week
0.8100 +11.57%
on 05/11/22
4.1000 -77.96%
on 06/09/21
-2.7763 (-75.44%)
since 05/26/21

Most Recent Stories

More News
Evogene (EVGN) Reports Q1 Loss, Lags Revenue Estimates

Evogene (EVGN) delivered earnings and revenue surprises of -42.86% and 46.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

EVGN : 0.9000 (-8.15%)
SRNE : 1.5550 (+7.99%)
Vascular Biogenics (VBLT) Reports Q1 Loss, Misses Revenue Estimates

Vascular Biogenics (VBLT) delivered earnings and revenue surprises of -8.33% and 42.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

VBLT : 1.7600 (+4.76%)
EVGN : 0.9000 (-8.15%)
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates

Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 16.67% and 20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

SYRS : 0.7396 (+7.19%)
EVGN : 0.9000 (-8.15%)
Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of 35.71% and 19.27%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

FBIO : 0.8703 (+6.13%)
EVGN : 0.9000 (-8.15%)
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Misses Revenue Estimates

Tarsus Pharmaceuticals, Inc. (TARS) delivered earnings and revenue surprises of -12.64% and 90.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the...

TARS : 14.07 (-2.90%)
EVGN : 0.9000 (-8.15%)
Evogene (EVGN) Reports Q4 Loss, Tops Revenue Estimates

Evogene (EVGN) delivered earnings and revenue surprises of 10% and 107.33%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

EVGN : 0.9000 (-8.15%)
ANGN : 1.3000 (+3.17%)
Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica's Microbiome-Based Immuno-Oncology Drug

/PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....

EVGN : 0.9000 (-8.15%)
EverGen Infrastructure Corp. Completes Initial Public Offering

Not for distribution to U.S. news wire services or dissemination in the U.S.

EVGN : 0.9000 (-8.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene...

See More

Key Turning Points

3rd Resistance Point 1.1001
2nd Resistance Point 1.0450
1st Resistance Point 1.0125
Last Price 0.9000
1st Support Level 0.9249
2nd Support Level 0.8698
3rd Support Level 0.8373

See More

52-Week High 4.1000
Fibonacci 61.8% 2.8432
Fibonacci 50% 2.4550
Fibonacci 38.2% 2.0668
Last Price 0.9000
52-Week Low 0.8100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar